Surprise, surprise. Sussex backs chemistry

Over the past few weeks, the leadership of the University of Sussex, in England, has faced a barrage of criticism from scientists, media and linkurl:politicians;http://www.the-scientist.com/news/display/23404/ over plans to linkurl:reshape its chemistry department;http://www.the-scientist.com/news/display/23404/ in favor of biological chemistry. The planned restructuring, widely seen as the brainchild of vice chancellor Alasdair Smith, was denigrated by a Nobel Laureate, protested against by st

Written byStephen Pincock
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Over the past few weeks, the leadership of the University of Sussex, in England, has faced a barrage of criticism from scientists, media and linkurl:politicians;http://www.the-scientist.com/news/display/23404/ over plans to linkurl:reshape its chemistry department;http://www.the-scientist.com/news/display/23404/ in favor of biological chemistry. The planned restructuring, widely seen as the brainchild of vice chancellor Alasdair Smith, was denigrated by a Nobel Laureate, protested against by students and ripped to shreds by members of the House of Commons. The good news for everyone, then, is that the university's council agreed today to support a plan that will see chemistry surviving--albeit as part of a departmental merger with biochemistry. The decision is not surprising in iteself, and had been linkurl:trailed;http://www.the-scientist.com/news/display/23404/ by the University last week. But perhaps the most interesting aspect of the whole thing is that Smith has turned into the plan's biggest supporter. In a press release on Friday, he said: "I have always made clear that I hoped the outcome of the process will be to secure a strong future for chemistry at Sussex." The University's Senate last week "overwhelmingly" agreed that the approach "proposed by the Vice-Chancellor" was the way ahead, according to the release. The plan which now has the support of the vice chancellor will see investment in up to 11 posts across the life sciences - in chemistry and biochemistry, biology and environmental science, genomics and psychology. It could be approved by the Council in June.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies